Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
108.36
(
0.82%
)
Bitcoin
76,953.04
(
-0.59%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 64
Posts 11880
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: adreamer post# 165700

Tuesday, 08/27/2013 12:45:44 PM

Tuesday, August 27, 2013 12:45:44 PM

Post# of 257580
Very seldom ( unless some CEO wants to fall on his sword) would anyone want to procure a bio that has make-it or break-it trial results on the horizon. Today, Ariad is cheap if the trials are positive and very expensive if the trials fail.

We'll have to wait awhile to find the real value of ariad.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today